A Quality Assurance Framework for End-to-End Compliance in the Pharmaceutical Product Lifecycle: A Review

Maintaining compliance throughout the entire product lifecycle is essential for contemporary pharmaceutical quality systems. This process encompasses all stages, starting from the initial product development to commercial manufacturing, overseeing post-approval lifecycles, and ultimately the discontinuation of products. The pharmaceutical sector is progressively embracing a Quality Assurance (QA) framework that aligns with the product lifecycle to guarantee adherence to international regulatory standards. Regulatory authorities are progressively demanding that pharmaceutical firms demonstrate a comprehensive, lifecycle-focused strategy for quality management instead of isolated compliance initiatives. Quality Assurance (QA) plays an essential role within the Good Manufacturing Practices (GMP) framework, guaranteeing that pharmaceutical products adhere to safety, efficacy, and regulatory requirements. From the development phase through to distribution, QA is involved in every aspect of the product lifecycle, promoting compliance and ongoing enhancement. The assessment highlights at new trends in lifecycle-focused QA frameworks, strengthening QA-driven lifecycle strategies as a key for maintaining long-term regulatory compliance, ensuring consistent product quality, and enhancing patient safety and its information.